Business Update
CytoCore engages Beaufort Advisors as U.S. FDA consultants for trials and product manufacturing
Published in Cancer Weekly, August 15th, 2006
CytoCore's CEO David Weissberg stated, "We have essentially completed our financial restructuring efforts and are entering into the next phase of our development activities. We have clinical trials and product manufacturing that we are about to launch. In order to maximize our success with these activities, it requires senior regulatory advice and guidance. We wanted to find a group that had successfully consulted with early-stage medical device companies. With Beaufort Advisors, we believe we have a firm that will strongly complement our existing team as we move...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-08-15)
More Articles from Cancer Weekly
- Breast Cancer
Breast cancer invasiveness linked to low glucose levels - Carcinogenesis
Arsenic implicated in etiology of cancer - Diagnostics
Br-76-1 proposed as potential PET radiotracer for imaging solid tumors - Adenovirus Pathogenesis
Adenovirus type 2 and type 5 E1A genes are expressed at different levels - Adverse Drug Reaction
Cantharidin-induced cytotoxicity in the bladder linked to cyclooxygenase 2 expression - Adverse Drug Reaction
Chronic exposure of tumor cells to PD98059 decreased inhibitory effect - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
